Human Enterohepatic Cell Model for Predictive Toxicology
用于预测毒理学的人类肠肝细胞模型
基本信息
- 批准号:7459078
- 负责人:
- 金额:$ 33.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressAdsorptionAlginatesArtificial LiverArtsBiochemicalBiochemical PathwayBioinformaticsBiological ModelsBiomedical EngineeringBioreactorsBloodBlood flowCell Culture TechniquesCell ExtractsCell LineCell TherapyCell modelCellsChemicalsCollaborationsCollagen Type ICompatibleComputer softwareConditionCost ControlCulture TechniquesCultured CellsDataDatabasesDevelopmentDrug Delivery SystemsDrug IndustryEncapsulatedExtracellular MatrixGasesGenotypeGlutamineGlycineGoalsHepaticHepatocyteHeterogeneityHumanIn SituIn VitroIndustryInsulinIntestinesLiverMarketingMedicineMetabolicMetabolic PathwayMetabolismMethodsModelingMonitorMultinuclear NMRNumbersOrganismOrphanOxygenPathway interactionsPatientsPharmaceutical PreparationsPharmacologic SubstancePhase III Clinical TrialsPhenobarbitalPhenotypePlasmaPopulationPyruvatePyruvatesRateRattusReactionRecipeResearchResourcesStem cellsStreamSumSystemTechnologyTherapeuticTimeTissuesTodayToxic effectToxicologyWorkWritingabstractinganalytical methodbasebody systemcell preparationcell typecostdaydesigndrug developmentdrug testingin vitro Modelin vivo Modelmecarzolemetabolomicsnovelpre-clinical researchprogenitorstemsuccesstooltrendtroglitazonetwo-dimensional
项目摘要
DESCRIPTION (provided by applicant):
It costs half a trillion dollars to bring a drug candidate to market. This expense is causing pharmaceutical companies to focus on compounds that have the greatest earning potential, orphan the development of critically needed drugs that have low revenue projections, and transfer high research costs to the consumer. All of these industry trends significantly increase the number of patients who can not access needed medicine because it is unavailable or unaffordable. The pharmaceutical industry is attempting to address this problem by heavily investing in human pre-clinical research as a mechanism to control cost and enhance the success of drug development. The industry is anxious for new tools to support the human pre-clinical research initiative. There is a particular need for advanced in vitro model systems to evaluate the toxicity of chemicals and drugs. This project's goal is to develop such a system.
Abstract:
The current in vitro technology for testing drug candidates is based on two-dimensional (2-D) sandwich livercell culturing techniques developed four decades ago. These In vivo models are complicated by the presence of structural and functional heterogeneity of biochemical pathways at the tissue and organism levels, and do not allow for mechanisms to be clearly defined or reproducibly examined. An in vitro system that is a much better model of a human liver is needed. Over the past dozen years this research team has been developing a state-of-the-art multicoaxial bioreactor (MCB) for creating the first human bioartificial liver. Over the past four years the team has focused on identifying the optimum human liver cell population for seeding the three-dimensional (3-D) bioreactor cultures. It has been determined that an unfractionated mixture of human liver cells shown to contain hepatic stem/progenitors provides favorable bioreactor results. In addition to this work the team has developed versatile NMR-compatible bioreactors that can obtain in situ metabolomics and fluxomics data.
In this project we will create the first 3-D human bioartificial entero-hepatic organ-system and establish the feasibility of using this model system to evaluate the toxicity of chemicals and drugs. The proposed technology will be based on incorporating a defined population of human liver cells in an extracellular matrix thus creating a microenvironment composed of a precise composition of insoluble factors to interact with the cells. The encapsulated hepatocytes will be placed in a bioreactor compartment adjacent to a compartment containing a human derived- intestinal cell line, CaCo-2. This will be achieved using two multiple compartment bioreactor designs; a multicoaxial bioreactor (MCB) and a NMR-compatible bioreactor. The proposed bioreactor designs contain at least 4 compartments. This will permit the two cell types to interact across a small space and be perfused by separate plasma/intestinal compartments representing the blood and the intestinal compartments. This will mimic blood flow of the human entero-hepatic system. The advantage of the MCB bioreactor is that the intestinal barrier is better replicated. The advantage of the NMR-compatible bioreactor is that a novel interleaved NMR method can obtain in situ metabolomic and fluxomic data simultaneously from the two tissues. The expected result of this project will be an artificial human liver model that will be used with computational metabolomic and fluxomic analysis to identify toxicological and pharmacological drug targets.
描述(由申请人提供):
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Lyn regulates creatine uptake in an imatinib-resistant CML cell line.
Lyn 调节伊马替尼耐药 CML 细胞系中肌酸的摄取。
- DOI:10.1016/j.bbagen.2019.129507
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Okumu,DenisO;Aponte-Collazo,LucasJ;Dewar,BrianJ;Cox,NathanJ;East,MichaelP;Tech,Katherine;McDonald,IanM;Tikunov,AndreyP;Holmuhamedov,Ekhson;Macdonald,JeffreyM;Graves,LeeM
- 通讯作者:Graves,LeeM
¹³C magnetic resonance spectroscopy detection of changes in serine isotopomers reflects changes in mitochondrial redox status.
13C磁共振波谱检测丝氨酸同位素的变化反映了线粒体氧化还原状态的变化。
- DOI:10.1002/mrm.23296
- 发表时间:2012
- 期刊:
- 影响因子:3.3
- 作者:Johnson,CBryce;Tikunov,AndreyP;Lee,Haakil;Wolak,JustynaE;Pediaditakis,Peter;Romney,DougA;Holmuhamedov,Ekhson;Gamcsik,MichaelP;Macdonald,JeffreyM
- 通讯作者:Macdonald,JeffreyM
Direct Detection of Glutathione Biosynthesis, Conjugation, Depletion and Recovery in Intact Hepatoma Cells.
- DOI:10.3390/ijms23094733
- 发表时间:2022-04-25
- 期刊:
- 影响因子:5.6
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey M. Macdonald其他文献
Introduction to Metabolic Control Analysis (MCA)
代谢控制分析 (MCA) 简介
- DOI:
10.1007/978-1-61779-618-0_9 - 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
Maliackal Poulo Joy;T. Elston;Andrew N. Lane;Jeffrey M. Macdonald;M. Cascante - 通讯作者:
M. Cascante
13-cis-retinoic acid-mediated growth inhibition of DU-145 human prostate cancer cells.
13-顺式视黄酸介导的 DU-145 人前列腺癌细胞生长抑制。
- DOI:
- 发表时间:
1994 - 期刊:
- 影响因子:0
- 作者:
R. Dahiya;B. Boyle;H.;J. Kurhanewicz;Jeffrey M. Macdonald;Perinchery Narayan - 通讯作者:
Perinchery Narayan
Role of voltage-dependent anion channels of the mitochondrial outer membrane in regulation of cell metabolism
线粒体外膜电压依赖性阴离子通道在细胞代谢调节中的作用
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:0
- 作者:
E. Holmuhamedov;C. Czerny;Gregory L. Lovelace;Craig C. Beeson;T. Baker;C. B. Johnson;P. Pediaditakis;V. Teplova;A. Tikunov;Jeffrey M. Macdonald;J. Lemasters - 通讯作者:
J. Lemasters
Application of Magnetic Resonance for Metabolomic Investigation of Mollusks
- DOI:
10.1016/j.bpj.2010.12.3490 - 发表时间:
2011-02-02 - 期刊:
- 影响因子:
- 作者:
Andrey P. Tikunov;Haakil Lee;Michael K. Stoskopf;Jeffrey M. Macdonald - 通讯作者:
Jeffrey M. Macdonald
Jeffrey M. Macdonald的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey M. Macdonald', 18)}}的其他基金
Human Enterohepatic Cell Model for Predictive Toxicology
用于预测毒理学的人类肠肝细胞模型
- 批准号:
7268038 - 财政年份:2006
- 资助金额:
$ 33.12万 - 项目类别:
Human Enterohepatic Cell Model for Predictive Toxicology
用于预测毒理学的人类肠肝细胞模型
- 批准号:
7012944 - 财政年份:2006
- 资助金额:
$ 33.12万 - 项目类别:
DETERMINAT OF RADIAL FLOW BY MR MICROSCOPY IN COAXIAL BIOARTIFICIAL LIVER LOBULE
磁共振显微镜测定同轴生物人工肝小叶的径向血流
- 批准号:
6493747 - 财政年份:2001
- 资助金额:
$ 33.12万 - 项目类别:
DETERMINAT OF RADIAL FLOW BY MR MICROSCOPY IN COAXIAL BIOARTIFICIAL LIVER LOBULE
通过磁共振显微镜测定同轴生物人工肝小叶的径向血流
- 批准号:
6348180 - 财政年份:2000
- 资助金额:
$ 33.12万 - 项目类别:
DETERMINAT OF RADIAL FLOW BY MR MICROSCOPY IN COAXIAL BIOARTIFICIAL LIVER LOBULE
通过磁共振显微镜测定同轴生物人工肝小叶的径向血流
- 批准号:
6220737 - 财政年份:1999
- 资助金额:
$ 33.12万 - 项目类别:
RADIAL PERFUSION, DIFFUSION, OXYGEN IN COAXIAL BIOREACTOR: HUMAN HEPATOCYTE LINE
同轴生物反应器中的径向灌注、扩散、氧气:人肝细胞线
- 批准号:
6122321 - 财政年份:1999
- 资助金额:
$ 33.12万 - 项目类别:
NMR ANALYSIS OF BIOARTIFICAL LIVER FROM PROGENITORS
祖细胞生物人工肝的核磁共振分析
- 批准号:
2418487 - 财政年份:1998
- 资助金额:
$ 33.12万 - 项目类别:
RADIAL PERFUSION, DIFFUSION, OXYGEN IN COAXIAL BIOREACTOR: HUMAN HEPATOCYTE LINE
同轴生物反应器中的径向灌注、扩散、氧气:人肝细胞线
- 批准号:
6282356 - 财政年份:1998
- 资助金额:
$ 33.12万 - 项目类别:
NMR ANALYSIS OF BIOARTIFICAL LIVER FROM PROGENITORS
祖细胞生物人工肝的核磁共振分析
- 批准号:
2749415 - 财政年份:1998
- 资助金额:
$ 33.12万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.12万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.12万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.12万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.12万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.12万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.12万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.12万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.12万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.12万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.12万 - 项目类别:
Research Grant